Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis

Jocelyn Quistrebert, Signe Hässler, Delphine Bachelet, Cyprien Mbogning, Anne Musters, Paul P. Tak, Carla A. Wijbrandts, Marieke M. J. Herenius, Sytske Anne Bergstra, G. Akdemir,

Seminars in Arthritis and Rheumatism · 2018 · 56 citations · 37 references

DOIFull text

Open access

Concepts

References

37